Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to Climb

• Κύριοι συγγραφείς: Evlampia Strongyli (Συγγραφέας), Paschalis Evangelidis (Συγγραφέας), Ioanna Sakellari (Συγγραφέας), Maria Gavriilaki (Συγγραφέας), Eleni Gavriilaki (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2024-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Immunotherapy with chimeric antigen receptor T (CAR-T) cell therapies has brought substantial improvement in clinical outcomes in patients with relapsed/refractory B cell neoplasms. However, complications such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndr...